Cited by 1,000MicroRNA in disease regulationMetabolism, Diabetes, and CancerAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

MicroRNAs 103 and 107 regulate insulin sensitivity

Open access

Trajkovski, Mirko, Hausser, Jean, Soutschek, Jürgen, Bhat, Bal, Akin, Akinc, Zavolan, Mihaela, Heim, Markus H., Stoffel, Markus·2011·Nature

DOI 10.1038/nature10112

Open this paper in CoChat — free account Open PDF

Abstract

Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes. MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism. However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10112

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Self-citation
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,259
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
The multiple faces of caveolae
Parton, R. G., & Simons, K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2122 · Cited by 1,529
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177
MicroRNA-143 Regulates Adipocyte Differentiation
Esau, C., Kang, X., Peralta, E. R., Hanson, E. M., Marcusson, E. G., Ravichandran, L. V., Sun, Y., Koo, S., Perera, R. J., Jain, R., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400438200 · Cited by 1,023
The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
Goossens, G. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.10.010 · Cited by 591

Show all 27 references

Sorted by citations

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rupaimoole, R., & Slack, F. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.246 · Cited by 4,741
Diabetic Cardiomyopathy
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,872
Adipose-derived circulating miRNAs regulate gene expression in other tissues
Thomou, T., Mori, M. A., Dreyfuss, J. M., Konishi, M., Sakaguchi, M., Wolfrum, C., Rao, T. N., Winnay, J. N., Garcia-Martin, R., Grinspoon, S. K., et al. (2017) · Nature · doi:10.1038/nature21365 · Cited by 1,539
An overview of microRNAs
Hammond, S. M. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.05.001 · Cited by 1,324
MicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,052
Molecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Targeting noncoding RNAs in disease
Adams, B. D., Parsons, C., Walker, L., Zhang, W. C., & Slack, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84424 · Cited by 678
MicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles
van Rooij, E., & Olson, E. N. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3864 · Cited by 631
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
Ratti, M., Lampis, A., Ghidini, M., Salati, M., Mirchev, M. B., Valeri, N., & Hahne, J. C. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00717-x · Cited by 632
Circulating microRNAs as novel biomarkers for diabetes mellitus
Guay, C., & Regazzi, R. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.86 · Cited by 563
Inhibition of microRNA function by antimiR oligonucleotides
Stenvang, J., Petri, A., Lindow, M., Obad, S., & Kauppinen, S. (2012) · Silence · doi:10.1186/1758-907x-3-1 · Cited by 571
Developing MicroRNA Therapeutics
van Rooij, E., Purcell, A. L., & Levin, A. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247916 · Cited by 449
Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs
Frost, R. J., & Olson, E. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118922109 · Cited by 461
Interplay between miRNAs and human diseases
Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., Singha, R. S., Malakar, A. K., & Chakraborty, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25854 · Cited by 420
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
Rotman, Y., & Sanyal, A. J. (2016) · Gut · doi:10.1136/gutjnl-2016-312431 · Cited by 420
Microbiota depletion promotes browning of white adipose tissue and reduces obesity
Suárez-Zamorano, N., Fabbiano, S., Chevalier, C., Stojanović, O., Colin, D. J., Stevanović, A., Veyrat-Durebex, C., Tarallo, V., Rigo, D., Germain, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3994 · Cited by 403
Self-citation
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 390
Micro RNA s in metabolism
Vienberg, S. G., Geiger, J., Madsen, S., & Dalgaard, L. T. (2016) · Acta Physiologica · doi:10.1111/apha.12681 · Cited by 385
MicroRNAs and their roles in aging
Smith-Vikos, T., & Slack, F. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.099200 · Cited by 333
A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13
Grueter, C. E., van Rooij, E., Johnson, B. A., DeLeon, S. M., Sutherland, L. B., Qi, X., Gautron, L., Elmquist, J. K., Bassel‐Duby, R., & Olson, E. N. (2012) · Cell · doi:10.1016/j.cell.2012.03.029 · Cited by 368
MicroRNA-mediated regulation of glucose and lipid metabolism
Agbu, P., & Carthew, R. W. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00354-w · Cited by 376
MicroRNAs in Common Human Diseases
Li, Y., & Kowdley, K. V. (2012) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.07.005 · Cited by 372
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics
Deiuliis, J. A. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.170 · Cited by 365
Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b
Kornfeld, J., Baitzel, C., Könner, A. C., Nicholls, H. T., Vogt, M. C., Herrmanns, K., Scheja, L., Haumaître, C., Wolf, A. M., Knippschild, U., et al. (2013) · Nature · doi:10.1038/nature11793 · Cited by 347
Self-citation
Lipid rafts in immune signalling: current progress and future perspective
Varshney, P., Yadav, V., & Saini, N. (2016) · Immunology · doi:10.1111/imm.12617 · Cited by 345
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 335
Epigenetic Regulation of the DLK1-MEG3 MicroRNA Cluster in Human Type 2 Diabetic Islets
Kameswaran, V., Bramswig, N. C., McKenna, L. B., Penn, M. M. C., Schug, J., Hand, N. J., Chen, Y., Choi, I., Vourekas, A., Won, K., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.016 · Cited by 324
The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs
Virtue, A. T., McCright, S. J., Wright, J. M., Jimenez, M. T., Mowel, W. K., Kotzin, J. J., Joannas, L., Basavappa, M. G., Spencer, S. P., Clark, M. L., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav1892 · Cited by 317
Lipid-based carriers of microRNAs and intercellular communication
Vickers, K. C., & Remaley, A. T. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328350a425 · Cited by 314
Selective Insulin and Leptin Resistance in Metabolic Disorders
Könner, A. C., & Brüning, J. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.004 · Cited by 320
Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*
Carrer, M., Liu, N., Grueter, C. E., Williams, A. H., Frisard, M. I., Hulver, M. W., Bassel‐Duby, R., & Olson, E. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207605109 · Cited by 305
MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion
Soh, J., Iqbal, J., Queiroz, J., Fernandez-Hernando, C. F., & Hussain, M. M. (2013) · Nature Medicine · doi:10.1038/nm.3200 · Cited by 303
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 307
The miRNA Plasma Signature in Response to Acute Aerobic Exercise and Endurance Training
Nielsen, S. J., Akerstrom, T. C. A., Rinnov, A., Yfanti, C., Schéele, C., Pedersen, B. K., & Laye, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087308 · Cited by 306
Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression
Nielsen, L. B., Wang, C., Sørensen, K., Bang‐Berthelsen, C. H., Hansen, L. B., Andersen, M.-L. M., Hougaard, P., Juul, A., Zhang, C., Pociot, F., et al. (2012) · Experimental Diabetes Research · doi:10.1155/2012/896362 · Cited by 289
A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism
Xu, Y., Zalzala, M. H., Xu, J., Li, Y., Yin, L., & Zhang, Y. (2015) · Nature Communications · doi:10.1038/ncomms8466 · Cited by 279
Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies
Zhu, H., & Leung, S. W. (2015) · Diabetologia · doi:10.1007/s00125-015-3510-2 · Cited by 273
MicroRNA-103/107 Regulate Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury Through Targeting FADD
Wang, J., Zhang, X.-J., Li, Q., Wang, K., Wang, Y., Jiao, J.-Q., Feng, C., Sun, T., Zhou, L., Gong, Y., et al. (2015) · Circulation Research · doi:10.1161/circresaha.117.305781 · Cited by 265
MyomiR-133 regulates brown fat differentiation through Prdm16
Trajkovski, M., Ahmed, K., Esau, C., & Stoffel, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2612 · Cited by 263
Self-citation
MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels
Goedeke, L., Rotllan, N., Canfrán-Duque, A., Aranda, J. F., Ramírez, C. M., Araldi, E., Lin, C.-S., Anderson, N. N., Wagschal, A., de Cabo, R., et al. (2015) · Nature Medicine · doi:10.1038/nm.3949 · Cited by 238
Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers
Pescador, N., Pérez‐Barba, M., Ibarra, J. M., Anchuelo, A. C., Martínez-Larrad, M. T., & Serrano‐Ríos, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077251 · Cited by 259
MicroRNAs in Metabolic Disease
Fernández-Hernando, C., Ramírez, C. M., Goedeke, L., & Suárez, Y. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300144 · Cited by 257
The clinical potential of circulating microRNAs in obesity
Ji, C., & Guo, X. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0260-0 · Cited by 263
Circadian Oscillations of Protein-Coding and Regulatory RNAs in a Highly Dynamic Mammalian Liver Epigenome
Vollmers, C., Schmitz, R. J., Nathanson, J. L., Yeo, G. W.-M., Ecker, J. R., & Panda, S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.004 · Cited by 260
MicroRNA-based therapeutics in central nervous system injuries
Sun, P., Liu, D. Z., Jickling, G. C., Sharp, F. R., & Yin, K.-J. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18773871 · Cited by 228
Elevated micro RNA ‐34a in obesity reduces NAD + levels and SIRT 1 activity by directly targeting NAMPT
Choi, S., Fu, T., Seok, S., Kim, D., Yu, E., Lee, K. W., KANG, Y. Y., Li, X., KEMPER, B. W., & Kemper, J. K. (2013) · Aging Cell · doi:10.1111/acel.12135 · Cited by 251
MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids
Fu, X., Dong, B., Tian, Y., Lefèbvre, P., Meng, Z., Wang, X., Pattou, F. N., Han, W., Wang, X., Lou, F., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75438 · Cited by 253
MicroRNAs in Vascular and Metabolic Disease
Zampetaki, A., & Mayr, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.247445 · Cited by 247
Infected erythrocyte-derived extracellular vesicles alter vascular function via regulatory Ago2-miRNA complexes in malaria.
Mantel, P.-Y., Hjelmqvist, D., Walch, M., Kharoubi-Hess, S., Nilsson, S., Ravel, D., Ribeiro, M., Grüring, C., Ma, S., Padmanabhan, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms12727 · Cited by 237
Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes
Chakraborty, C., Doss, C. G. P., Bandyopadhyay, S., & Agoramoorthy, G. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1240 · Cited by 243
Gut Microbiota as an Epigenetic Regulator: Pilot Study Based on Whole-Genome Methylation Analysis
Kumar, H., Lund, R., Laiho, A., Lundelin, K., Ley, R. E., Isolauri, E., & Salminen, S. (2014) · mBio · doi:10.1128/mbio.02113-14 · Cited by 236
Role of microRNAs in obesity and obesity-related diseases
Iacomino, G., & Siani, A. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0577-z · Cited by 232
Salidroside ameliorates insulin resistance through activation of a mitochondria‐associated AMPK / PI3K / A kt/ GSK 3β pathway
Zheng, T., Yang, X., Wu, D., Xing, S., Bian, F., Li, W., Chi, J., Bai, X., Wu, G., Chen, X., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13120 · Cited by 230
Biomarkers of liver cell death
Eguchi, A., Wree, A., & Feldstein, A. E. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.026 · Cited by 220
MicroRNAs and Metabolism Crosstalk in Energy Homeostasis
Dumortier, O., Hinault, C., & OBBERGHEN, E. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.004 · Cited by 220
Roles of microRNA on cancer cell metabolism
Chen, B., Li, H., Zeng, X., Yang, P., Liu, X., Zhao, X., & Liang, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-228 · Cited by 206
Spatial sorting enables comprehensive characterization of liver zonation
Ben-Moshe, S., Shapira, Y., Moor, A. E., Manco, R., Veg, T., Bahar Halpern, K., & Itzkovitz, S. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0109-9 · Cited by 205
Spatial sorting enables comprehensive characterization of liver zonation
Ben-Moshe, S., Shapira, Y., Moor, A. E., Halpern, K. B., & Itzkovitz, S. (2019) · doi:10.1101/529784 · Cited by 205
The miRNA Profile of Human Pancreatic Islets and Beta-Cells and Relationship to Type 2 Diabetes Pathogenesis
van de Bunt, M., Gaulton, K. J., Parts, L., Morán, I., Johnson, P. R. V., Lindgren, C. M., Ferrer, J. P., Gloyn, A. L., & McCarthy, M. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055272 · Cited by 201
Antidiabetic Potential of Flavonoids from Traditional Chinese Medicine: A Review
Bai, L., Li, X., He, L., Zheng, Y., Lu, H., Li, J., Zhong, L., Tong, R., Jiang, Z., Shi, J., et al. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500496 · Cited by 207
MicroRNA-15a and MicroRNA-16 Impair Human Circulating Proangiogenic Cell Functions and Are Increased in the Proangiogenic Cells and Serum of Patients With Critical Limb Ischemia
Spinetti, G., Fortunato, O., Caporali, A., Shantikumar, S., Marchetti, M., Meloni, M., Descamps, B., Floris, I., Sangalli, E., Vono, R., et al. (2012) · Circulation Research · doi:10.1161/circresaha.111.300418 · Cited by 198
Of mice and men: models and mechanisms of diabetic cardiomyopathy
Riehle, C., & Bauersachs, J. K. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 204
Regulation of metabolism by long, non-coding RNAs
Kornfeld, J., & Brüning, J. C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00057 · Cited by 197
Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia
Sandoval, D. A., & Patti, M. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00757-5 · Cited by 218
Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy
Mori, M. A., Thomou, T., Boucher, J., Lee, K. Y., Lallukka, S., Kim, J. K., Torriani, M., Yki‐Järvinen, H., Grinspoon, S. K., Cypess, A. M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73468 · Cited by 189
Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets
Loganathan, T., & Doss, C. G. P. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-022-00947-4 · Cited by 196
MicroRNA binding sites in the coding region of mRNAs: Extending the repertoire of post‐transcriptional gene regulation
Brümmer, A., & Hausser, J. (2014) · BioEssays · doi:10.1002/bies.201300104 · Cited by 170
Self-citation
Circulating adipocyte‐derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass
Hubal, M. J., Nadler, E. P., Ferrante, S. C., Barberio, M. D., Suh, J., Wang, J. Z., Dohm, G. L., Pories, W. J., Mietus‐Snyder, M., & Freishtat, R. J. (2016) · Obesity · doi:10.1002/oby.21709 · Cited by 190
Molecular Targets Related to Inflammation and Insulin Resistance and Potential Interventions
Hirabara, S. M., Gorjão, R., Vinolo, M. A. R., Rodrigues, A. C., Nachbar, R. T., & Curi, R. (2012) · BioMed Research International · doi:10.1155/2012/379024 · Cited by 180
MicroRNA-small molecule association identification: from experimental results to computational models
Chen, X., Guan, N., Sun, Y., Li, J., & Qu, J. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby098 · Cited by 177
MicroRNAs in adipose tissue: their role in adipogenesis and obesity
Hilton, C., Neville, M. J., & Karpe, F. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.59 · Cited by 177
microRNA-103a Functions as a Mechanosensitive microRNA to Inhibit Bone Formation Through Targeting Runx2
Zuo, B., Zhu, J., Li, J., Wang, C., Zhao, X., Cai, G., Li, Z., Peng, J., Wang, P., Shen, C., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2352 · Cited by 175
Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research
Willebrords, J., Pereira, I. V. A., Maes, M., Yanguas, S. C., Colle, I. O., Bossche, B. V. D., da Silva, T. C., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A. F., et al. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.05.002 · Cited by 177
Current Advances in RNA Therapeutics for Human Diseases
Zogg, H., Singh, R., & Ro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052736 · Cited by 180
Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
Lai, X., Eberhardt, M., Schmitz, U., & Vera, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz638 · Cited by 170
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
Hochreuter, M. Y., Dall, M., Treebak, J. T., & Barrès, R. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101581 · Cited by 180
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
ller, G. M. A. U. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s32923 · Cited by 178
Insulin Resistance and Cancer: In Search for a Causal Link
CHIEFARI, E. D., Mirabelli, M., Vignera, S. L., Tanyolaç, S., FOTI, D. P., Aversa, A., & Brunetti, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011137 · Cited by 180
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 197
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154
MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells
Srivastava, S. K., Bhardwaj, A., Singh, S., Arora, S., Wang, B., Grizzle, W. E., & Singh, A. P. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr223 · Cited by 162
Metabolic memory: mechanisms and diseases
Dong, H., Sun, Y., Nie, L., Cui, A., Zhao, P., Leung, W. K., & Wang, Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01755-x · Cited by 186
Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK–miR-107–Eomes–PD-1 Pathway
Zhang, Z., Li, F., Tian, Y., Cao, L., Gao, Q., Zhang, C., Zhang, K., Shen, C., Ping, Y., Maimela, N. R., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901213 · Cited by 162
MiR-27 orchestrates the transcriptional regulation of brown adipogenesis
Sun, L., & Trajkovski, M. (2013) · Metabolism · doi:10.1016/j.metabol.2013.10.004 · Cited by 159
Self-citation
MicroRNA 33 Regulates Glucose Metabolism
Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00016-13 · Cited by 154
MicroRNAs in Insulin Resistance and Obesity
Williams, M. D., & Mitchell, G. M. (2012) · Experimental Diabetes Research · doi:10.1155/2012/484696 · Cited by 158
The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes
Sharma, M., Li, Y., Stoll, M. L., & Tollefsbol, T. O. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01329 · Cited by 156
Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults
Wang, R., Hong, J., Cao, Y., Shi, J., Gu, W., Ning, G., Zhang, Y., & Wang, W. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0867 · Cited by 151
Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho
Fu, T., Choi, S., Kim, D.-H., Seok, S., Suino-Powell, K. M., Xu, H. E., & Kemper, J. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205951109 · Cited by 150
The Early Origins of Obesity and Insulin Resistance: Timing, Programming and Mechanisms
Nicholas, L. M., Morrison, J. L., Rattanatray, L., Zhang, S., Ozanne, S. E., & McMillen, I. C. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.178 · Cited by 146
N6-Adenosine Methylation in MiRNAs
Berulava, T., Rahmann, S., Rademacher, K., Klein‐Hitpass, L., & Horsthemke, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118438 · Cited by 144
Role of microRNAs in the modulation of diabetic retinopathy
Mastropasqua, R., Toto, L., Cipollone, F., Santovito, D., Carpineto, P., & Mastropasqua, L. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.003 · Cited by 144
Regulatory Roles of MicroRNAs in Diabetes
Feng, J., Xing, W., & Xie, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101729 · Cited by 144
MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target
Mellis, D. J., & Caporali, A. (2017) · Biochemical Society Transactions · doi:10.1042/bst20170037 · Cited by 141
Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4
Hartmann, P., Zhou, Z., Natarelli, L., Wei, Y., Nazari-Jahantigh, M., Zhu, M., Grommes, J., Steffens, S., Weber, C., & Schober, A. (2016) · Nature Communications · doi:10.1038/ncomms10521 · Cited by 140
MiR-103a-3p targets the 5′ UTR of GPRC5A in pancreatic cells
Zhou, H., & Rigoutsos, I. (2014) · RNA · doi:10.1261/rna.045757.114 · Cited by 137
MicroRNA-181b Improves Glucose Homeostasis and Insulin Sensitivity by Regulating Endothelial Function in White Adipose Tissue
Sun, X., Lin, J., Zhang, Y., Kang, S., Belkin, N., Wara, A. K., Icli, B., Hamburg, N. M., Li, D., & Feinberg, M. W. (2016) · Circulation Research · doi:10.1161/circresaha.115.308166 · Cited by 133

Authors: Trajkovski, M., Hausser, J., Soutschek, J., Bhat, B., Akin, A., Zavolan, M., Heim, M. H., & Stoffel, M.
Affiliations: ETH Zurich (CH)
University of Basel (CH)
Regulus Therapeutics (United States) (US)
University Hospital of Basel (CH)
Corresponding author: Stoffel, Markus
ORCID: Trajkovski, Mirko
Hausser, Jean
Zavolan, Mihaela
Heim, Markus H.
Stoffel, Markus
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2011-06
Volume: 474
Issue: 7353
Pages: 649-653
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10112
OpenAlex: W2075317528
Cited by: 1,000
References: 27
Citations by year: 2026: 36 · 2025: 34 · 2024: 54 · 2023: 45 · 2022: 61 · 2021: 61 · 2020: 71 · 2019: 68 · 2018: 80 · 2017: 65 · 2016: 98 · 2015: 90 · 2014: 90 · 2013: 77 · 2012: 57
FWCI: 25.77
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
RePEc: Research Papers in Economics (submittedVersion)
BIROn (Birkbeck, University of London) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders: National Science Foundation
Juvenile Diabetes Research Foundation International
Fondation Leducq
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: microRNA-107, insulin sensitivity, caveolin-1, insulin signaling, insulin receptor, glucose homeostasis, obesity, type 2 diabetes, adipocytes, liver, insulin-stimulated glucose uptake, adipocyte size, miRNA target genes
MeSH terms: Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Gene Expression Regulation, Glucose, Homeostasis, Hyperglycemia, Insulin, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Up-Regulation, Gene Expression, Adipocytes, Gene Silencing, MicroRNAs, Cell Size, Caveolin 1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MicroRNAs 103 and 107 regulate insulin sensitivity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks